Author: Mike Clague Aesthetic Nurse BSC
Date Posted:6 November 2018
Thanks for taking the time to invest in your knowledge. Keeping up with clinical publications is hard. At FacecoachLIVE we hope to help you stay safe.
This paper was a review of a case of blindness that was reversed with a subcutaneous injection of hyaluronidase into the nose.
Siti Nurhuda Sharudin et al ; July 2018
To get this paper click here - Neuro-Opthalmology - https://www.tandfonline.com/doi/abs/10.1080/01658107.2018.1482358
A 31 year old Chinese woman was injected with HA filler into the dorsum of the nose and glabella for nose augmentation. She was injected 12 hours prior to presentation. She presented with mono-ocular visual impairment associated with diplopia.
She experienced severe right peri-orbital pain immediately after injection followed by severe vision loss in the inferior half of her visual field.
The patient was treated 12 hours after injection with the HA filler with 60 units of hyaluronidase across the dorsum of the nose and glabella.
The patient experienced visual recovery at 2 weeks. The authors discussed some limitations of the case study but it is a promising publication.
We recommend you read this article.
If you are in Australia you should attend our 'Safety with Dermal Fillers Workshop' in 3 hours we cover all the latest published data on blindness and dermal fillers.
You should keep current and read your clinical publications. Revise important anatomy. Know your limitations.
If you are doing training, check your trainers experience. At Facecoach LIVE our trainers have at least 10 years experience in medical aesthetics. Do your research as to which training company offers you the best outcomes for your patients.
We teach in our classes (ASSOC PROF GOODMAN) -
Comments have to be approved before showing up